Skip to Main Content

LABU  Direxion Daily S&P Biotech Bull 3X…
Exchange-Traded Fund
NYSE Arca

Morningstar Summary

Ratings & Reports

  • Overall
    as of --
    Star Rating: 0Not Rated
    Out of -- funds
  • 3 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 5 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 10 Year
    Star Rating: 0Not Rated
    Out of -- funds

Historical Risk

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Historical Return

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Morningstar Style Box

Market Cap vs. Investment Style
Selected Values: Investment Style: Small, Market Cap: Growth
Value
Blend
Growth
Large
Mid
Small

Price Movement of LABU

Chart for Price Movement
LABU is up 2.21% over the last 3 days.
Bid/Ask1$89.50 / $93.44
Open$0.00
Previous Close$88.23
Day Low/High
Last Price
$88.23  0% or $32,856.23 from its Day low
--
--
52 Week Range
Last Price
$88.23  8% or $4.67 from its 52 Week high
$33.82
1/24/2017
$92.90
1/16/2018
Price/Earnings--
Price/Cash Flow--
Price/Revenue9.30x

Fund Detail

as of 12/31/2017

Profile

Profile
Total Net Assets$404.7 M
Premium/Discount-0.18%
Portfolio Turnover642.00%
Total Holdings14
Fund TypeETF
Transaction FeeYes

Distributions and Yield

Distributions and Yield
Distribution Yield0.17%
Most Recent Dividend$0.1326
Previous Pay Date12/20/2017
Ex-Date12/13/2017
Distribution FrequencyQuarterly
SEC Yield--

Total Returns

as of 12/31/2017

Standardized Returns

Standardized Returns: Monthly
Description3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception
LABU Market Price
6.96%131.03%-------19.87%-8.75%149.10%-------23.56%-8.75%149.10%-------23.56%
LABU NAV
7.28%131.99%-------19.87%-8.77%148.69%-------24.11%-8.77%148.69%-------24.11%
Trading--Leveraged Equity
Morningstar Category
------------3.07%15.53%20.57%18.63%6.36%--3.19%9.51%24.83%16.48%5.43%--
S&P 500
Index
9.78%25.63%13.85%15.89%10.11%10.83%6.64%21.83%11.41%15.79%8.50%10.73%6.64%21.83%11.41%15.79%8.50%10.73%
View Performance >

Top 5 Holdings

as of 12/31/2017
Top 5 Holdings
--S&P BIOTECHNOLOGY SELECT3.78%
XBIOpens Flyout Module that includes Quote information for linked symbolSPDR® S&P Biotech ETF2.75%
--S&P Biotechnology Select Industry USD2.16%
--S&P Biotechnology Select1.23%
--S&P Biotechnology Select1.07%
Total
10.99%
More Holdings >

Top Sectors

as of 12/31/2017
Top SectorsTop Sectors
Sector% of Holdings
Healthcare100.00%
Industrials0.00%
Real Estate0.00%
Technology0.00%
Other0.00%
Total100.00%
Sign in to see if you own shares.
Additional Trading Options
Fund Highlights
Fund Strategy
The investment seeks daily investment results- before fees and expenses- of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund- under normal circumstances- invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that provide daily leveraged exposure to the index and/or exchange-traded funds ("ETFs") that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Morningstar Category
These funds seek to generate returns equal to a fixed multiple of the short-term returns of an equity index. The compounding of short-term returns results in performance that does not correspond to those of investing in the index with external leverage. For example, a fund attempting to achieve 2 times the returns of a given index on a daily basis is unlikely to deliver anything like 2 times the index's returns over periods longer than one day. Many of these funds seek to generate a multiple of the daily or weekly return of the reference index. Trading funds are not considered suitable for a long-term investor and are designed to be used by active traders.
  • Inception Date
    05/28/2015
  • 1.09%
    Net Expense may include reimbursements or fee waivers, which may be voluntary or contractual and may expire. See prospectus for more details.
  • Gross Expense Ratio
    1.11%
  • Index Fund
    Yes
  • Leveraged Fund
    Yes
  • Socially Conscious
    No
  • Actively Managed
    No
  • Fund Family
Opens a modal dialogOpens a modal dialogOpen flyout contentOpens a new window